Nyxoah SA Return on Tangible Equity 2021-2024 | NYXH
Current and historical return on tangible equity values for Nyxoah SA (NYXH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Nyxoah SA Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $-0.06B | $0.06B | -98.72% |
| 2024-06-30 | $-0.05B | $0.08B | -77.69% |
| 2024-03-31 | $-0.05B | $0.04B | -77.05% |
| 2023-12-31 | $-0.05B | $0.06B | -64.60% |
| 2023-09-30 | $-0.05B | $0.07B | -61.25% |
| 2023-06-30 | $-0.05B | $0.08B | -53.87% |
| 2023-03-31 | $-0.04B | $0.09B | -39.69% |
| 2022-12-31 | $-0.03B | $0.09B | -31.28% |
| 2022-06-30 | $-0.02B | $0.11B | -24.24% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||